Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Clinical trial NCT01360632 · COMPLETED

Trial details

NCT number: NCT01360632
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Depressive Disorder Depression Depressive Disorder, Major Mood Disorders Mental Disorders

Start date: 2011-06-01
Primary completion: 2013-08-01
Enrollment: 1539

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.